Global Crysvita Market Report 2025

Crysvita Global Market Report 2025 – By Type (10 mg, 20 mg, 30 mg), By Patient Demographics (Pediatric, Adult), By Disease Prevalence (X-Linked Hypophosphatemia, Tumor-Induced Osteomalacia), By Application (Hospitals, Clinics, Other Applications) – Market Size, Trends, And Global Forecast 2025-2034

Crysvita Global Market Report 2025

Report Price : $4490.00 | Pages : | Published : January 2025 | Delivery Time: 2-3 business days | Format : pdf

Need assistance or more information before the purchase?

Enquire Before Buying
Crysvita Global Market Report 2025

Proud Members Of

checkslacipN checkaoirsN checkscipN

Crysvita Market Definition

Crysvita is a prescription medication used to treat X-linked hypophosphatemia (XLH), a rare genetic disorder that leads to low levels of phosphate in the blood, resulting in weak bones, bone pain, and other skeletal issues.

The main types of crysvita are 10 mg, 20 mg, and 30 mg. CysVita 10 mg is a pharmaceutical product that typically contains cysteine as its active ingredient, often in the form of a cysteine-based supplement. These are used for various patient demographics such as pediatric, and adult. The various disease prevalences include x-linked hypophosphatemia, and tumor-induced osteomalacia and are used for various applications such as hospitals, clinics, and others.

Crysvita Market Segmentation

The crysvitamarket covered in this report is segmented –

1) By Type: 10 mg, 20 mg, 30 mg

2) By Patient Demographics: Pediatric, Adult

3) By Disease Prevalence: X-Linked Hypophosphatemia, Tumor-Induced Osteomalacia

4) By Application: Hospitals, Clinics, Other Applications

Crysvita Market Size and growth rate 2025 to 2029: Graph

Crysvita Market Size 2025 And Growth Rate

The crysvita market size has XX (HCAGR) in recent years. It will grow from $XX million in 2024 to $XX million in 2025 at a compound annual growth rate (CAGR) of XX%. The growth in the historic period can be attributed to increased focus on early diagnosis and intervention of genetic disorders, advancements in genetic research enabling precise identification of XLH, supportive healthcare initiatives promoting access to innovative treatments.

Crysvita Market Growth Forecast

The crysvita market size is expected to see XX (FCAGR) in the next few years. It will grow to $XX million in 2029 at a compound annual growth rate (CAGR) of XX%. The growth in the forecast period can be attributed to increasing efforts by patient advocacy groups to promote education and understanding, advancements in genetic research enabling earlier and more accurate diagnosis, greater focus on improving access to innovative, expanding healthcare initiatives targeting rare genetic disorders treatments. Major trends in the forecast period include managing XLH and TIO, with ongoing research and clinical experience contributing to its therapeutic profile.

Crysvita Market Driver: Rising Number of Clinical Trials To Accelerate Growth In The Crysvita Market

The increasing number of clinical trials is expected to propel the growth of the crysvita market going forward. Clinical trials play a crucial role in advancing the understanding and treatment of Acute Spinal Cord Injury (SCI). The increasing number of clinical trials is driven by demand for new treatments, medical advancements, personalized medicine, and rising healthcare needs. Crysvita helps clinical trials by providing a targeted treatment for X-linked hypophosphatemia, enabling the evaluation of its efficacy and safety in various patient populations. For instance, in August 2024, according to the United States National Library of Medicine, the number of registered clinical trials increased from 477,227 in 2023 to 506,371 in all 50 states and across 221 countries. Furthermore, it was reported that 52,731 medical device studies were registered across globe. Therefore, the increasing number of clinical trials drives the crysvita market.

Crysvita Market Driver: Rise Of Personalized Medicine Fueling Growth In The Market

Rising personalized medicine is expected to propel the growth of the Crysvita market going forward. Personalized medicine is a medical approach that tailors treatment and healthcare strategies to the individual characteristics of each patient, such as their genetic makeup, environment, and lifestyle, to achieve the most effective and precise outcomes. Advances in genomic technologies and better understanding of diseases allow for the development of targeted therapies tailored to individual genetic profiles. This combination is driving the rise of personalized medicine, improving treatment effectiveness and patient outcomes. Crysvita exemplifies personalized medicine by offering targeted treatment for X-linked hypophosphatemia (XLH), addressing the unique genetic and metabolic needs of individual patients to improve bone health and quality of life. For instance, in February 2024, according to a report published by the Personalized Medicine Coalition, a US-based organization, in 2023, the FDA approved 16 new personalized treatments for rare disease patients, up from six in 2022. The newly approved personalized treatments for 2023 also include seven cancer drugs and three for other diseases and conditions. Therefore, rising personalized medicine drives the crysvita market.

Global Crysvita Market Major Players

Major companies operating in the crysvita market include Kyowa Kirin Co. Ltd., Ultragenyx Pharmaceutical Inc.

Crysvita Market Merger And Acquisition: OMERS Capital Markets Acquires North American Royalties For Crysvita, Strengthening Investment In Rare Disease Market

In August 2022, OMERS Capital Markets, a Canada-based investment company that offers management, acquired a portion of North American royalties on Crysvita from Ultragenyx Pharmaceutical Inc. for $500 million. With this acquisition, OMERS Capital Markets enhances its investments in the rare disease market, recognizing the significant growth and patient impact of Crysvita. Ultragenyx Pharmaceutical Inc. is a U.S.-based biopharmaceutical company manufacturing Crysvita (burosumab).

Regional Outlook For The Global Crysvita Market

North America was the largest region in the crysvita market in 2024. The regions covered in the crysvita market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the crysvita market report are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada.

What Defines the Crysvita Market?

The crysvita market consists of sales of injection and drug formulation. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Crysvita Industry?

The crysvita market research report is one of a series of new reports from The Business Research Company that provides crysvita market statistics, including crysvita industry global market size, regional shares, competitors with a crysvita market share, detailed crysvita market segments, market trends, and opportunities, and any further data you may need to thrive in the crysvita industry. This crysvita market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Crysvita Market Report Forecast Analysis
Report AttributeDetails
Market Size Value In 2025 CAGR of from 2025 to 2034
Revenue Forecast In 2034 2024
Growth Rate 2019-2024
Base Year For Estimation 2025 - 2029 - 2034
Actual Estimates/Historical Data Revenue in USD Billion and CAGR from 2025 to 2034
Forecast Period 1) By Type: 10 mg, 20 mg, 30 mg
2) By Patient Demographics: Pediatric, Adult
3) By Disease Prevalence: X-Linked Hypophosphatemia, Tumor-Induced Osteomalacia
4) By Application: Hospitals, Clinics, Other Applications
Market Representation Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Segments Covered The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Regional Scope Kyowa Kirin Co. Ltd., Ultragenyx Pharmaceutical Inc.
Country Scope Request for Sample
Key Companies Profiled Explore Purchase Options
Customization Scope
Pricing And Purchase Options

    Table Of Contents

    1. Executive Summary

    2. Crysvita Market Characteristics

    3. Crysvita Market Biologic Drug Characteristics

    3.1. Molecule Type

    3.2. Route Of Administration (ROA)

    3.3. Mechanism Of Action (MOA)

    3.4. Safety And Efficacy

    4. Crysvita Market Trends And Strategies

    5. Crysvita Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

    6. Global Crysvita Growth Analysis And Strategic Analysis Framework

    6.1. Global Crysvita PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

    6.2. Analysis Of End Use Industries

    6.3. Global Crysvita Market Growth Rate Analysis

    6.4. Global Crysvita Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

    6.5. Global Crysvita Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

    6.6. Global Crysvita Total Addressable Market (TAM)

    7. Global Crysvita Market Pricing Analysis & Forecasts

    8. Crysvita Market Segmentation

    8.1. Global Crysvita Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    10 mg

    20 mg

    30 mg

    8.2. Global Crysvita Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Pediatric

    Adult

    8.3. Global Crysvita Market, Segmentation By Disease Prevalence, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    X-Linked Hypophosphatemia

    Tumor-Induced Osteomalacia

    8.4. Global Crysvita Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Hospitals

    Clinics

    Other Applications

    9. Global Crysvita Market Epidemiology Of Clinical Indications

    9.1. Drug Side Effects

    9.2. Incidence And Prevalence of Clinical Indications

    10. Crysvita Market Regional And Country Analysis

    10.1. Global Crysvita Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    10.2. Global Crysvita Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    11. Asia-Pacific Crysvita Market

    11.1. Asia-Pacific Crysvita Market Overview

    Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    11.2. Asia-Pacific Crysvita Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    11.3. Asia-Pacific Crysvita Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    11.4. Asia-Pacific Crysvita Market, Segmentation By Disease Prevalence, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    12. China Crysvita Market

    12.1. China Crysvita Market Overview

    12.2. China Crysvita Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

    12.3. China Crysvita Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

    12.4. China Crysvita Market, Segmentation By Disease Prevalence, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

    13. India Crysvita Market

    13.1. India Crysvita Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    13.2. India Crysvita Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    13.3. India Crysvita Market, Segmentation By Disease Prevalence, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    14. Japan Crysvita Market

    14.1. Japan Crysvita Market Overview

    14.2. Japan Crysvita Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    14.3. Japan Crysvita Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    14.4. Japan Crysvita Market, Segmentation By Disease Prevalence, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    15. Australia Crysvita Market

    15.1. Australia Crysvita Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    15.2. Australia Crysvita Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    15.3. Australia Crysvita Market, Segmentation By Disease Prevalence, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    16. South Korea Crysvita Market

    16.1. South Korea Crysvita Market Overview

    16.2. South Korea Crysvita Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    16.3. South Korea Crysvita Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    16.4. South Korea Crysvita Market, Segmentation By Disease Prevalence, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    17. Western Europe Crysvita Market

    17.1. Western Europe Crysvita Market Overview

    17.2. Western Europe Crysvita Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    17.3. Western Europe Crysvita Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    17.4. Western Europe Crysvita Market, Segmentation By Disease Prevalence, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    18. UK Crysvita Market

    18.1. UK Crysvita Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    18.2. UK Crysvita Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    18.3. UK Crysvita Market, Segmentation By Disease Prevalence, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    19. Germany Crysvita Market

    19.1. Germany Crysvita Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    19.2. Germany Crysvita Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    19.3. Germany Crysvita Market, Segmentation By Disease Prevalence, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    20. France Crysvita Market

    20.1. France Crysvita Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    20.2. France Crysvita Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    20.3. France Crysvita Market, Segmentation By Disease Prevalence, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    21. Eastern Europe Crysvita Market

    21.1. Eastern Europe Crysvita Market Overview

    21.2. Eastern Europe Crysvita Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    21.3. Eastern Europe Crysvita Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    21.4. Eastern Europe Crysvita Market, Segmentation By Disease Prevalence, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    22. North America Crysvita Market

    22.1. North America Crysvita Market Overview

    22.2. North America Crysvita Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    22.3. North America Crysvita Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    22.4. North America Crysvita Market, Segmentation By Disease Prevalence, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    23. USA Crysvita Market

    23.1. USA Crysvita Market Overview

    23.2. USA Crysvita Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    23.3. USA Crysvita Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    23.4. USA Crysvita Market, Segmentation By Disease Prevalence, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    24. Canada Crysvita Market

    24.1. Canada Crysvita Market Overview

    24.2. Canada Crysvita Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    24.3. Canada Crysvita Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    24.4. Canada Crysvita Market, Segmentation By Disease Prevalence, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    25. South America Crysvita Market

    25.1. South America Crysvita Market Overview

    25.2. South America Crysvita Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    25.3. South America Crysvita Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    25.4. South America Crysvita Market, Segmentation By Disease Prevalence, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    26. Middle East Crysvita Market

    26.1. Middle East Crysvita Market Overview

    26.2. Middle East Crysvita Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    26.3. Middle East Crysvita Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    26.4. Middle East Crysvita Market, Segmentation By Disease Prevalence, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    27. Africa Crysvita Market

    27.1. Africa Crysvita Market Overview

    27.2. Africa Crysvita Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    27.3. Africa Crysvita Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    27.4. Africa Crysvita Market, Segmentation By Disease Prevalence, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    28. Crysvita Market Competitive Landscape And Company Profiles

    28.1. Crysvita Market Competitive Landscape

    28.2. Crysvita Market Company Profiles

    28.2.1. Kyowa Kirin Co. Ltd. Overview, Products and Services, Strategy and Financial Analysis

    28.2.2. Ultragenyx Pharmaceutical Inc. Overview, Products and Services, Strategy and Financial Analysis

    29. Global Crysvita Market Pipeline Analysis

    29.1. High Level Clinic Trail Information

    30. Global Crysvita Market Competitive Benchmarking And Dashboard

    31. Key Mergers And Acquisitions In The Crysvita Market

    32. Recent Developments In The Crysvita Market

    33. Crysvita Market High Potential Countries, Segments and Strategies

    33.1 Crysvita Market In 2029 - Countries Offering Most New Opportunities

    33.2 Crysvita Market In 2029 - Segments Offering Most New Opportunities

    33.3 Crysvita Market In 2029 - Growth Strategies

    33.3.1 Market Trend Based Strategies

    33.3.2 Competitor Strategies

    34. Appendix

    34.1. Abbreviations

    34.2. Currencies

    34.3. Historic And Forecast Inflation Rates

    34.4. Research Inquiries

    34.5. The Business Research Company

    34.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Table 3: Global Crysvita Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 4: Global Crysvita Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 5: Global Crysvita Market, Segmentation By Disease Prevalence, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 6: Global Crysvita Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 7: Global Crysvita Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 8: Global Crysvita Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 9: Asia-Pacific, Crysvita Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 10: Asia-Pacific, Crysvita Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 11: Asia-Pacific, Crysvita Market, Segmentation By Disease Prevalence, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 12: China, Crysvita Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 13: China, Crysvita Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 14: China, Crysvita Market, Segmentation By Disease Prevalence, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 15: India, Crysvita Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 16: India, Crysvita Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 17: India, Crysvita Market, Segmentation By Disease Prevalence, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 18: Japan, Crysvita Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 19: Japan, Crysvita Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 20: Japan, Crysvita Market, Segmentation By Disease Prevalence, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 21: Australia, Crysvita Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 22: Australia, Crysvita Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 23: Australia, Crysvita Market, Segmentation By Disease Prevalence, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 24: South Korea, Crysvita Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 25: South Korea, Crysvita Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 26: South Korea, Crysvita Market, Segmentation By Disease Prevalence, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 27: Western Europe, Crysvita Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 28: Western Europe, Crysvita Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 29: Western Europe, Crysvita Market, Segmentation By Disease Prevalence, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 30: UK, Crysvita Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 31: UK, Crysvita Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 32: UK, Crysvita Market, Segmentation By Disease Prevalence, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 33: Germany, Crysvita Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 34: Germany, Crysvita Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 35: Germany, Crysvita Market, Segmentation By Disease Prevalence, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 36: France, Crysvita Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 37: France, Crysvita Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 38: France, Crysvita Market, Segmentation By Disease Prevalence, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 39: Eastern Europe, Crysvita Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 40: Eastern Europe, Crysvita Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 41: Eastern Europe, Crysvita Market, Segmentation By Disease Prevalence, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 42: North America, Crysvita Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 43: North America, Crysvita Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 44: North America, Crysvita Market, Segmentation By Disease Prevalence, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 45: USA, Crysvita Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 46: USA, Crysvita Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 47: USA, Crysvita Market, Segmentation By Disease Prevalence, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 48: Canada, Crysvita Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 49: Canada, Crysvita Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 50: Canada, Crysvita Market, Segmentation By Disease Prevalence, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 51: South America, Crysvita Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 52: South America, Crysvita Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 53: South America, Crysvita Market, Segmentation By Disease Prevalence, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 54: Middle East, Crysvita Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 55: Middle East, Crysvita Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 56: Middle East, Crysvita Market, Segmentation By Disease Prevalence, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 57: Africa, Crysvita Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 58: Africa, Crysvita Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 59: Africa, Crysvita Market, Segmentation By Disease Prevalence, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 60: Kyowa Kirin Co. Ltd. Financial Performance
  • Table 61: Ultragenyx Pharmaceutical Inc. Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Figure 3: Global Crysvita Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 4: Global Crysvita Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 5: Global Crysvita Market, Segmentation By Disease Prevalence, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 6: Global Crysvita Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 7: Global Crysvita Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 8: Global Crysvita Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 9: Asia-Pacific, Crysvita Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 10: Asia-Pacific, Crysvita Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 11: Asia-Pacific, Crysvita Market, Segmentation By Disease Prevalence, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 12: China, Crysvita Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 13: China, Crysvita Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 14: China, Crysvita Market, Segmentation By Disease Prevalence, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 15: India, Crysvita Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 16: India, Crysvita Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 17: India, Crysvita Market, Segmentation By Disease Prevalence, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 18: Japan, Crysvita Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 19: Japan, Crysvita Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 20: Japan, Crysvita Market, Segmentation By Disease Prevalence, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 21: Australia, Crysvita Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 22: Australia, Crysvita Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 23: Australia, Crysvita Market, Segmentation By Disease Prevalence, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 24: South Korea, Crysvita Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 25: South Korea, Crysvita Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 26: South Korea, Crysvita Market, Segmentation By Disease Prevalence, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 27: Western Europe, Crysvita Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 28: Western Europe, Crysvita Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 29: Western Europe, Crysvita Market, Segmentation By Disease Prevalence, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 30: UK, Crysvita Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 31: UK, Crysvita Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 32: UK, Crysvita Market, Segmentation By Disease Prevalence, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 33: Germany, Crysvita Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 34: Germany, Crysvita Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 35: Germany, Crysvita Market, Segmentation By Disease Prevalence, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 36: France, Crysvita Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 37: France, Crysvita Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 38: France, Crysvita Market, Segmentation By Disease Prevalence, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 39: Eastern Europe, Crysvita Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 40: Eastern Europe, Crysvita Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 41: Eastern Europe, Crysvita Market, Segmentation By Disease Prevalence, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 42: North America, Crysvita Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 43: North America, Crysvita Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 44: North America, Crysvita Market, Segmentation By Disease Prevalence, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 45: USA, Crysvita Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 46: USA, Crysvita Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 47: USA, Crysvita Market, Segmentation By Disease Prevalence, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 48: Canada, Crysvita Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 49: Canada, Crysvita Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 50: Canada, Crysvita Market, Segmentation By Disease Prevalence, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 51: South America, Crysvita Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 52: South America, Crysvita Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 53: South America, Crysvita Market, Segmentation By Disease Prevalence, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 54: Middle East, Crysvita Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 55: Middle East, Crysvita Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 56: Middle East, Crysvita Market, Segmentation By Disease Prevalence, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 57: Africa, Crysvita Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 58: Africa, Crysvita Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 59: Africa, Crysvita Market, Segmentation By Disease Prevalence, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 60: Kyowa Kirin Co. Ltd. Financial Performance
  • Figure 61: Ultragenyx Pharmaceutical Inc. Financial Performance
View Report
View Report
View Report
View Report
View Report
View Report
View Report
View Report

Frequently Asked Questions

What is the definition of the Crysvita market?

Crysvita is a prescription medication used to treat X-linked hypophosphatemia (XLH), a rare genetic disorder that leads to low levels of phosphate in the blood, resulting in weak bones, bone pain, and other skeletal issues. For further insights on the Crysvita market, request a sample here

How will the Crysvita market drivers and restraints affect the market dynamics? What forces will shape the Crysvita industry going forward?

The Crysvita market major growth driver - Rising Number of Clinical Trials To Accelerate Growth In The Crysvita Market. For further insights on the Crysvita market, request a sample here

What is the forecast market size or the forecast market value of the Crysvita market?

The Crysvita market size has grown strongly in recent years. The crysvita market size has XX (HCAGR) in recent years. It will grow from $XX million in 2024 to $XX million in 2025 at a compound annual growth rate (CAGR) of XX%. The growth in the historic period can be attributed to increased focus on early diagnosis and intervention of genetic disorders, advancements in genetic research enabling precise identification of XLH, supportive healthcare initiatives promoting access to innovative treatments . The crysvita market size is expected to see XX (FCAGR) in the next few years. It will grow to $XX million in 2029 at a compound annual growth rate (CAGR) of XX%. The growth in the forecast period can be attributed to increasing efforts by patient advocacy groups to promote education and understanding, advancements in genetic research enabling earlier and more accurate diagnosis, greater focus on improving access to innovative, expanding healthcare initiatives targeting rare genetic disorders treatments. Major trends in the forecast period include managing XLH and TIO, with ongoing research and clinical experience contributing to its therapeutic profile. For further insights on the Crysvita market, request a sample here

How is the Crysvita market segmented?

The crysvitamarket covered in this report is segmented –
1) By Type: 10 mg; 20 mg; 30 mg
2) By Patient Demographics: Pediatric; Adult
3) By Disease Prevalence: X-Linked Hypophosphatemia; Tumor-Induced Osteomalacia
4) By Application: Hospitals; Clinics; Other Applications For further insights on the Crysvita market,
request a sample here

Which region has the largest share of the Crysvita market? What are the other regions covered in the report?

North America was the largest region in the crysvita market in 2024. The regions covered in the crysvita market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on the Crysvita market, request a sample here.

Who are the major players in the Crysvita market?

Major companies operating in the crysvita market include Kyowa Kirin Co. Ltd., Ultragenyx Pharmaceutical Inc. . For further insights on the Crysvita market, request a sample here.

What are the key trends in the Crysvita market?

Major trends in the Crysvita market include . For further insights on the Crysvita market, request a sample here.

What are the major opportunities in the Crysvita market? What are the strategies for the Crysvita market?

For detailed insights on the major opportunities and strategies in the Crysvita market, request a sample here.

How does the Crysvita market relate to the overall economy and other similar markets?

For detailed insights on Crysvita's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the Crysvita industry?

For detailed insights on the mergers and acquisitions in the Crysvita industry, request a sample here.

What are the key dynamics influencing the Crysvita market growth? SWOT analysis of the Crysvita market.

For detailed insights on the key dynamics influencing the Crysvita market growth and SWOT analysis of the Crysvita industry, request a sample here.